Human Influenza A(H3N2) virus, A/Franche_Comte/01892/2023, epidemic isolate clade 3C.2a1b.2a.2
virus

Human Influenza A(H3N2) virus, A/Franche_Comte/01892/2023, epidemic isolate clade 3C.2a1b.2a.2

REFERENCE STRAIN

EVAg
Produced by
: IP
Shipping From
: Paris - FR

Product Description

Ref-SKU:
017V-05465
Human Influenza A(H3N2) virus, A/Franche_Comte/01892/2023, isolate of 2022-2023 epidemic season
Product Risk Group: 
RG2
ICTV Taxonomy: 
Riboviria / Orthornavirae / Negarnaviricota / Polyploviricotina / Insthoviricetes / Articulavirales / Orthomyxoviridae / Alphainfluenzavirus / Influenza A virus
Virus name: 
Influenza A virus
Strain: 
A/Franche_Comte/01892/2023
Genotype: 
3C.2a1b.2a.2
Serotype: 
A/Darwin/9/2021-like

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
one vial of 500ul clarified supernatant

In stock

500,00 €
 (Cost per access for Academics)
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Special feature: 
Reference Strain
GMO: 
No
Biosafety restrictions: 
BSL2 procedures
Virus host type: 
Human virus
Production cell line: 
1
04E+09 PFU/mL
Virus Cultivability: 
Cultivable virus
Passage: 
C2
Shipping conditions: 
Dry ice
IATA Classification: 
Category B, UN3373

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Monday, 16 January, 2023
Country of collection: 
France
Suspected epidemiological origin : 
Franche Comté
Isolation host: 
Human
female
Isolation technique: 
3 days incubation in MDCK cell culture
Isolation conditions: 
35°C and 5% CO2
Clinical information: 
Female, 59 years old, nasopharyngal